Concepedia

Publication | Closed Access

1208P Final results of APOLLO study: Overall survival (OS) of aumolertinib in patients with pretreated EGFR T790M-positive locally advanced or metastatic non-small cell lung cancer (NSCLC)

10

Citations

0

References

2021

Year

No additional data available for this publication yet. Check back later!